This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Syntroleum Vigorously Defends Bio-Synfining (R) Technology Against Neste Allegations

TULSA, Okla., Dec. 21, 2012 (GLOBE NEWSWIRE) -- On December 20, 2012, Syntroleum Corporation (Nasdaq:SYNM) was sued for alleged patent infringement in the District of Delaware by Neste Oil Oyj regarding U.S. Patent No. 8,212,094. The '094 patent covers similar subject matter and shares a common inventor with prior Neste patents (U.S. Patent Nos. 7,279,018 and 8,187,344), as they are directed to processes for making, or compositions of, diesel fuel or diesel range hydrocarbons. Syntroleum has not infringed any of Neste's alleged patent rights and Syntroleum will continue to vigorously defend against Neste's allegations. The '094 patent, like the '018 and '344 patents, adds nothing new to the field of diesel fuels or methods for making same. All claims of Neste's prior '018 patent were invalidated following a March 22, 2012 decision by the USPTO Board of Patent Appeals and Interferences finding that "the evidence of record as a whole supports the Examiner's conclusion that the fuel composition as claimed would have been obvious to one of ordinary skill in the art..." Neste declined to appeal this ruling and on July 31, 2012, the USPTO issued a Reexamination Certificate canceling all claims of the '018 patent. Likewise, the related '344 patent is the subject of an inter partes reexamination wherein the USPTO issued a September 14, 2012 Office Action rejecting all claims of that patent as obvious in view of the prior art. This reexamination is pending and is assigned Reexam Control Number 95002084.

Syntroleum is currently defending Neste's suit filed May 29, 2012 on the '344 patent in the District of Delaware. Syntroleum's Answer and Counterclaims to Neste's First Amended Complaint regarding the '344 patent was filed on September 24, 2012, and Syntroleum's Motion to Stay the district court action in view of the USPTO reexamination proceedings is pending. Syntroleum will pursue its non-infringement, invalidity and other defenses with respect to both asserted Neste patents and is confident that its position will be vindicated.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
SYM TRADE IT LAST %CHG

Markets

DOW 18,285.74 +0.34 0.00%
S&P 500 2,130.82 +4.97 0.23%
NASDAQ 5,090.7940 +19.0510 0.38%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs